Literature DB >> 7534188

Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids.

K Hirokawa1, K M O'Shaughnessy, P Ramrakha, M R Wilkins.   

Abstract

1. These studies examine the effect of retinoids on interleukin 1 beta (IL-1 beta)-induced nitric oxide synthase (NOS) activity in cultured rat aortic vascular smooth muscle (VSM) cells and isolated rat aortic rings. 2. All-trans-retinoic acid (all-trans-RA, 0.1-10 microM) and its active analogues produced concentration-dependent inhibition of IL-1 beta (0.1-10 ng ml-1)-induced nitrite production in cultured VSM cells. In contrast, the inactive retinoid, Ro 14-6113 (0.1-10 microM), had no effect on IL-1 beta-induced nitrite production. 3. Since some of the actions of retinoids are mediated by induction of transforming growth factor beta (TGF-beta), its effect on inducible NOS activity in VSM cells was examined. TGF-beta produced concentration-dependent (0.1-10 ng ml-1) inhibition of IL-1 beta-induced nitrite production and the maximum effect (approximately 90% inhibition) was significantly greater than that seen with all-trans-RA (approximately 70% with 10 microM). However, an anti-TGF-beta antibody (50 micrograms ml-1) which blocked the effect of exogenous TGF-beta (5 ng ml-1) did not significantly reverse the inhibitory action of all-trans-RA (10 microM). 4. In addition to inhibiting IL-1 beta-induced nitrite production, all-trans-RA (10 microM) reduced substantially inducible NOS mRNA and protein levels in IL-1 beta-induced VSM cells (P < 0.01). 5. Incubation of isolated rat aortic rings with IL-1 beta (10 ng ml-1) caused a progressive resistance of the rings to the vasoconstrictor action of phenylephrine (10 nM to 10 microM). This effect was abolished by the addition of the nitric oxide synthase inhibitor L-NG-monomethyl-L-arginine (L-NMMA, 1 mM). All trans-RA (10 micro M) also markedly and significantly reversed this IL-1p-induced vascular hyporeactivity(P<0.01).6. These data show that all-trans-RA and other active retinoids are able to block cytokine-stimulated expression of inducible NOS in cultured VSM cells and isolated aortic rings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534188      PMCID: PMC1510519          DOI: 10.1111/j.1476-5381.1994.tb17159.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Retinoic acid is a negative regulator of AP-1-responsive genes.

Authors:  R Schüle; P Rangarajan; N Yang; S Kliewer; L J Ransone; J Bolado; I M Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 2.  Vitamin A metabolism: new perspectives on absorption, transport, and storage.

Authors:  R Blomhoff; M H Green; J B Green; T Berg; K R Norum
Journal:  Physiol Rev       Date:  1991-10       Impact factor: 37.312

Review 3.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 4.  Vitamin A mediated gene expression.

Authors:  F Chytil
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1990       Impact factor: 1.807

5.  Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.

Authors:  D Beasley; J H Schwartz; B M Brenner
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.

Authors:  A Zembowicz; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages.

Authors:  F Q Cunha; S Moncada; F Y Liew
Journal:  Biochem Biophys Res Commun       Date:  1992-02-14       Impact factor: 3.575

8.  9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.

Authors:  A A Levin; L J Sturzenbecker; S Kazmer; T Bosakowski; C Huselton; G Allenby; J Speck; C Kratzeisen; M Rosenberger; A Lovey
Journal:  Nature       Date:  1992-01-23       Impact factor: 49.962

9.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site.

Authors:  R C Nicholson; S Mader; S Nagpal; M Leid; C Rochette-Egly; P Chambon
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  6 in total

1.  Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

Authors:  T Claudel; M D Leibowitz; C Fiévet; A Tailleux; B Wagner; J J Repa; G Torpier; J M Lobaccaro; J R Paterniti; D J Mangelsdorf; R A Heyman; J Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

2.  The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.

Authors:  Y Nozaki; T Yamagata; B-S Yoo; M Sugiyama; S Ikoma; K Kinoshita; M Funauchi; A Kanamaru
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

3.  Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis.

Authors:  P K Datta; R S Reddy; E A Lianos
Journal:  Inflammation       Date:  2001-12       Impact factor: 4.092

4.  Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. I. Effects after oral administration.

Authors:  E A Romero-Sandoval; C Molina; M Alique; V Moreno-Manzano; F J Lucio; J F Herrero
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

5.  All-Trans Retinoic Acid Modulates TLR4/NF-κB Signaling Pathway Targeting TNF-α and Nitric Oxide Synthase 2 Expression in Colonic Mucosa during Ulcerative Colitis and Colitis Associated Cancer.

Authors:  Hayet Rafa; Sarra Benkhelifa; Sonia AitYounes; Houria Saoula; Said Belhadef; Mourad Belkhelfa; Aziza Boukercha; Ryma Toumi; Imene Soufli; Olivier Moralès; Yvan de Launoit; Hassen Mahfouf; M'hamed Nakmouche; Nadira Delhem; Chafia Touil-Boukoffa
Journal:  Mediators Inflamm       Date:  2017-03-20       Impact factor: 4.711

6.  Light-Mediated Inhibition of Colonic Smooth Muscle Constriction and Colonic Motility via Opsin 3.

Authors:  William Dan; Ga Hyun Park; Shruti Vemaraju; Amy D Wu; Kristina Perez; Meenakshi Rao; Dan E Berkowitz; Richard A Lang; Peter D Yim
Journal:  Front Physiol       Date:  2021-12-16       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.